KD

Kalpana Dwivedi

Active Director Director DIN 06826224
DIN 06826224 First appointment Jul 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Kalpana Dwivedi

Data last updated:

Kalpana Dwivedi is a Director at Kingson Pharmaceuticals Private Limited (since 2022). The company operates in Trading. Kingson Pharmaceuticals Private Limited reported revenue of ₹15.8 Lakh (FY 2025).

DIN 06826224
Primary Designation Director
Industry Trading
First Appointment 11 Jul 2022
Oldest Company Age 12 yrs
Largest company Kingson Pharmaceuticals Private Limited · ₹15.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jul 20222014₹15.8 Lakh (FY 2025)Active

Board colleagues of Kalpana Dwivedi

Directorship timeline

Open interactive timeline →
Kingson Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kalpana Dwivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalpana Dwivedi

Kalpana Dwivedi currently holds 1 directorship: Kingson Pharmaceuticals Private Limited (Director, since 11 Jul 2022, revenue ₹15.8 Lakh (FY 2025)).

Kalpana Dwivedi was first appointed on 11 Jul 2022 as Director at Kingson Pharmaceuticals Private Limited.

The current boards of Kalpana Dwivedi's companies include Om Namo Narayan Dwivedi (Kingson Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available